Intraperitoneal Mesh With 3cm Overlap Versus a Rives-Stoppa Repair With a 6cm Overlap in Hernia Umbilicalis
Not Applicable
Completed
- Conditions
- Hernia, Umbilical
- Registration Number
- NCT00323141
- Lead Sponsor
- University Hospital, Ghent
- Brief Summary
To study the advantages and disadvantages of a Ventralex prothesis versus Light Weight Vypro II prothesis in patients with a hernia umbilicalis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Symptomatic hernia umbilicalis
- > 18 years old
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of relapses after 1 and 3 years after 1 and 3 years
- Secondary Outcome Measures
Name Time Method Duration of surgery Depends from type of surgery. Duration of hospitalisation Depends from type of surgery. Frequency of complications After 1 and 3 years. Pain assessment After 1 and 3 years.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Ventralex and Light Weight Vypro II prostheses in hernia repair?
How does intraperitoneal mesh with 3cm overlap compare to Rives-Stoppa repair with 6cm overlap in umbilical hernia recurrence rates?
Are there specific biomarkers that predict better outcomes with Ventralex versus Light Weight Vypro II prostheses in hernia surgery?
What are the potential adverse events associated with Ventralex and Light Weight Vypro II prostheses in hernia repair?
What are the current standard-of-care treatments for umbilical hernias and how do they compare to the prostheses studied in NCT00323141?
Trial Locations
- Locations (1)
University Hospital Ghent
🇧🇪Ghent, Belgium
University Hospital Ghent🇧🇪Ghent, Belgium